Crossmark

Dual agonist occupancy of AT1-R–α2C-AR heterodimers results in atypical Gs-PKA signaling

Crossref DOI link: https://doi.org/10.1038/nchembio.1766

Published Online: 2015-02-23

Published Print: 2015-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bellot, Morgane

Galandrin, Ségolène

Boularan, Cédric

Matthies, Heinrich J

Despas, Fabien

Denis, Colette

Javitch, Jonathan

Mazères, Serge

Sanni, Samra Joke

Pons, Véronique

Seguelas, Marie-Hélène

Hansen, Jakob L

Pathak, Atul

Galli, Aurelio

Sénard, Jean-Michel

Galés, Céline
License Information

Text and Data Mining valid from 2015-02-23
More Information

Article History

Received: 19 December 2013

Accepted: 9 January 2015

First Online: 23 February 2015

Competing interests

: J.L.H. is an employee of Novo Nordisk and is a shareholder of Novo Nordisk.